Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carmen Vidal, MD"'
Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data
Autor:
Margitta Worm, MD, Pascal Demoly, MD, PhD, Yoshitaka Okamoto, MD, PhD, Carmen Vidal, MD, PhD, Katia Daghildjian, PharmD, PhD, Kwok Yan, MD, Thomas B. Casale, MD, Karl-Christian Bergmann, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 7, Pp 100924- (2024)
Background: The 300IR house dust mite (HDM) sublingual immunotherapy (SLIT) tablet is approved for treatment of HDM-induced allergic rhinitis (AR). To provide a comprehensive review of the 300IR HDM-SLIT tablet safety profile based on randomized cont
Externí odkaz:
https://doaj.org/article/ac90c98e6af64991ba2b3588e845607e
Autor:
Oliver Pfaar, MD, PhD, Frédéric De BLAY, MD, Giorgio Walter Canonica, MD, Thomas B. Casale, MD, PhD, Philippe Gevaert, MD, PhD, Peter W. Hellings, MD, PhD, Krzysztof Kowal, MD, PhD, Giovanni Passalacqua, MD, Miguel Tortajada-Girbés, MD, PhD, Carmen Vidal, MD, PhD, Margitta Worm, MD, PhD, Farah Bahbah, MD, Pascal Demoly, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 1, Pp 100849- (2024)
Background: House dust mite (HDM)-induced allergic rhinitis (AR) is a major cause of allergic respiratory disease. The efficacy and safety of the 300 IR HDM sublingual immunotherapy (SLIT) tablet in patients with moderate-to-severe HDM-AR was confirm
Externí odkaz:
https://doaj.org/article/43594bc3e5774527b1542f3db97a9f03
Autor:
Pablo Rodriguez del Rio, MD, PhD, Davide Caimmi, MD, PhD, Pilar Rico Nieto, MD, PhD, Carmen Vidal, MD, PhD, Carmen Moreno, MD, PhD, Maria Teresa González-Fernández, MD, Margarita Tomás-Pérez, MD, Ana Beristain, MD, Isa Bosse, MD, Hoai Bich Trinh, MD, Thomas B. Casale, MD, PhD, Pascal Demoly, MD, PhD, Moises A. Calderon, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 6, Pp 100791- (2023)
Background: There is no description of the drivers of prescription for allergen immunotherapy (AIT) for respiratory allergic diseases. Methods: A prospective, multicentre, observational, non-interventional real-life study was performed in France and
Externí odkaz:
https://doaj.org/article/c55d2d49a2774697955dbe019fde873e
Autor:
Davide Caimmi, MD, PhD, Pablo Rodríguez del Río, MD, PhD, Pilar Rico, MD, PhD, Carmen Vidal, MD, Carmen Moreno, MD, Thomas B. Casale, MD, PhD, Pascal Demoly, MD, PhD, Moises A. Calderón, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 2, Pp 100749- (2023)
Background: Allergen immunotherapy (AIT) is today the only etiological therapy for respiratory allergic diseases, including allergic rhinitis, allergic conjunctivitis, and allergic asthma. Even though interest in real-world data has recently increase
Externí odkaz:
https://doaj.org/article/78026997c724405eb77f89d26e0911fd